Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

NCT03249376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: Lumateperone
OTHER: Placebo

Sponsor

Intra-Cellular Therapies, Inc.